Cargando…
SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas
BACKGROUND: Prostate carcinomas are initially dependent on androgens, and castration or androgen antagonists inhibit their growth. After some time though, tumors become resistant and recur with a poor prognosis. The majority of resistant tumors still expresses a functional androgen receptor (AR), fr...
Autores principales: | Compagno, Daniel, Merle, Carole, Morin, Aurélie, Gilbert, Cristèle, Mathieu, Jacques R. R., Bozec, Aline, Mauduit, Claire, Benahmed, Mohammed, Cabon, Florence |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994591/ https://www.ncbi.nlm.nih.gov/pubmed/17925854 http://dx.doi.org/10.1371/journal.pone.0001006 |
Ejemplares similares
-
Post-transcriptional gene silencing mediated by microRNAs is controlled by nucleoplasmic Sfpq
por: Bottini, Silvia, et al.
Publicado: (2017) -
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
por: Ban, Fuqiang, et al.
Publicado: (2021) -
Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011) -
Development and Evaluation of a PSMA-Targeted Nanosystem Co-Packaging Docetaxel and Androgen Receptor siRNA for Castration-Resistant Prostate Cancer Treatment
por: Zhang, Yingying, et al.
Publicado: (2022) -
Chronic crude garlic-feeding modified adult male rat testicular markers: mechanisms of action
por: Hammami, Imen, et al.
Publicado: (2009)